Showing results (121-130 of 143) with videos related to
Sort By:
Pageof 15
Translational Lung Cancer Research|August 12, 2022
Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker studyLukas Käsmann, Julian Taugner, Chukwuka Eze, et al.International Journal of Cancer|April 18, 2026
Development and Release of the Munich UICC Staging Tool (MUST): Advancing UICC Staging in Real-World Data With Insights From Pancreatic and Stomach CancerBrigitte Kühnel, Sophie Schneiderbauer, Sebastian Lange, et al.European Journal of Cancer (Oxford, England : 1990)|April 23, 2025
German S2k-guideline on diagnostics, treatment and surveillance of low-grade appendiceal mucinous neoplasms (LAMN)Franziska Köhler, Dirk Arnold, Daniela Aust, et al.Allergy|July 4, 2019
Impaired memory B-cell development and antibody maturation with a skewing toward IgE in patients with STAT3 hyper-IgE syndromeWillem van de Veen, Carolin E Krätz, Craig I McKenzie, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 18, 2020
Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized TrialsArndt Stahler, Sebastian Stintzing, Dominik P Modest, et al.Journal of Cancer Research and Clinical Oncology|August 30, 2024
Tumor board simulation improves interdisciplinary decision-making in medical studentsKevin Fink, Marie Forster, Matthias Oettle, et al.Anti-Cancer Drugs|June 6, 2017
Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancerArndt Stahler, Volker Heinemann, Jens Neumann, et al.European Journal of Cancer (Oxford, England : 1990)|September 10, 2021
Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial)Arndt Stahler, Volker Heinemann, Veronika Schuster, et al.International Journal of Cancer|October 28, 2020
Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survivalJohannes Thurmaier, Volker Heinemann, Jutta Engel, et al.Emerging Infectious Diseases|May 20, 2023
Microscopic Evidence of Malaria Infection in Visceral Tissue from Medici Family, ItalyFrank Maixner, Dennis Drescher, Giulia Boccalini, et al.Pageof 15